anthracycline-free

Neoadjuvant treatment with an anthracycline-free regimen in Breast Cancer – Breast International Group

Breast International Group shared a post on X:

“SABCS24.

P3-11-03 poster on results of phase 2 DECRESCENDO study:

Neoadjuvant treatment with an anthracycline-free regimen in patients with HER2-positive, HR-negative, node-negative early breast cancer resulted in a high rate of pCR.”

For more updates, follow OncoDaily.

Anthracycline anthracycline-free Breast Cancer Breast International Group cancer DECRESCENDO study EU4Health HaDEA Jules Bordet Institute neoadjuvant treatment OncoDaily Oncology SABCS24